NephriaBio

Curated by Signal

Provider of wearable hemodialysis therapy device

Overview

Provider of wearable hemodialysis therapy device. The company offers AI-based adaptive kidney therapy that utilizes a full suite of sensors that lower the risk of serious issues during therapy.

Key facts

Founded: 2020
Headquarters: Portsmouth, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CereSync
AI-powered assessment tools in treating dementia
Health TechnologyNew York City, United States
HomecareCRM
Sales and marketing platform for healthcare providers
Health TechnologyBirmingham, United States
Done Desk
Practice management platform for dentists
Health TechnologySan Antonio, United States

About NephriaBio

What does NephriaBio do?

Provider of wearable hemodialysis therapy device.

Where is NephriaBio headquartered?

NephriaBio is headquartered in Portsmouth, United States.

When was NephriaBio founded?

NephriaBio was founded in 2020.

Which sector is NephriaBio in?

NephriaBio operates in Health Technology.

Who are NephriaBio's competitors?

Companies similar to NephriaBio include CereSync, HomecareCRM, and Done Desk.